IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sarissa Capital Management LP

Q4 2018 Holdings

Filed 2019-02-14 | 10 holdings | $139.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biogen Inc.(BIIB)COM09062X103$139.0M461,85899.7%
Abbvie Inc.(ABBV)COM00287Y109$92.0K1,0000.1%
Innoviva Inc.(INVA)COM45781M101$88.1K5,051,1000.1%
Allergan PLCSHSG0177J108$73.0K546,5000.1%
Ironwood Pharmaceuticals Inc.(IRWD)COM CL A46333X108$64.8K6,252,3000.0%
Medicines Co.COM584688105$53.2K2,781,0000.0%
Puma Biotechnology Inc.(PBYI)COM74587V107$27.3K1,343,0000.0%
Intercept Pharmaceuticals Inc.(ICPTUSD)COM45845P108$5.4K54,0000.0%
Shire PLCSPONSORED ADR82481R106$1741,0000.0%
Mirati Therapeutics Inc.(MRTXEUR)COM60468T105$421,0000.0%